By Editor , 25 September 2026
Autoimmune Treatment Market to Nearly Double to $321.95B by 2034

Pune – September 24, 2026 -- The global autoimmune treatment market reached USD 176.6 billion in 2025 and is forecast to expand at a 6.9% CAGR through 2034, hitting USD 321.95 billion, according to a new analysis from Maximize Market Research.

By Editor , 25 September 2026
Nanomedicine Market to Nearly Triple to $581.2B by 2034

Pune, India – September 24, 2026 -- The global nanomedicine market reached USD 207.91 billion in 2025 and is projected to hit USD 581.2 billion by 2034, expanding at a 12.1% compound annual growth rate, according to a new report from Maximize Market Research.

By Editor , 25 September 2026
MS Treatment Market to Hit $44.45B by 2034 on DMT Demand

Pune, India – September 24, 2026 -- The global multiple sclerosis treatment market reached USD 26.76 billion in 2025 and is forecast to climb to USD 44.45 billion by 2034, expanding at a 5.8% CAGR, according to a new report from Maximize Market Research.

By Editor , 25 September 2026
Bioinformatics Market to Hit $64.60B by 2034 on NGS, AI Demand

Pune – September 24, 2026 -- The global bioinformatics market is projected to expand from $20.34 billion in 2025 to $64.60 billion by 2034, a 13.7% compound annual growth rate, according to new analysis from Maximize Market Research.

By Editor , 24 September 2026
Bladder Cancer Treatment Market to Hit $11.33B by 2034

Pune, India – September 24, 2026 -- The global bladder cancer treatment market was valued at $5.13 billion in 2025 and is projected to reach $11.33 billion by 2034, expanding at a 9.2% compound annual growth rate, according to a new analysis from Maximize Market Research.

By Editor , 23 September 2026
Exosomes Market to Hit $2.25B by 2034 on 28.8% CAGR

Pune, India – – September 22, 2026 -- The global exosomes market is set to grow nearly tenfold over the next decade, expanding from USD 230.55 million in 2025 to USD 2,250 million by 2034, according to a new analysis from Maximize Market Research. The projected 28.8% compound annual growth rate between 2026 and 2034 places exosome technology among the fastest-expanding segments in biopharmaceutical R&D.

By Editor , 23 September 2026
Lateral Flow Assay Market to Reach $16.37B by 2031, Grows 8.2%

Sheridan, Wyoming – – September 22, 2026 -- The global lateral flow assay market is set to expand from $11.04 billion in 2026 to $16.37 billion by 2031, a compound annual growth rate of 8.2%, according to a new study by Wissen Research.